tHEORetically Speaking
Menu Close
  • Home
  • Guest Authors
  • About Us
  • HealthEconomics.Com
  • HE Jobs Portal

comparative effectiveness

0

Good, Bad, or Indifferent on Drug Pricing: A Value Benchmark Approach for Newly Launched Drugs in the United States.

Posted on July 30, 2015 by Swarali Tadwalkar

Hardly a day goes by without a new article being published in the mainstream press or a medical journal discussing drug pricing.  The cost of drugs is a hot potato topic at medical meetings, pharma conference rooms, government hearings, and… Continue Reading →

cost-effectiveness, health economic models, health outcome models, modeling, Pharmaceutical Pricing, simulation, Value Access benchmark reports, comparative effectiveness, cost-effectiveness analysis, Dan Ollendorf, Emerging Therapy Assessment and Pricing, Evidence-based medicine, ICER, Institute for Clinical and Economic Review, patti peeples, pharmaceutical industry, Steve Pearson

About the HealthEconomics.Com Blog:

Insights, observations, executive interviews, critical analysis, and new research for health economics, outcomes research, real-world evidence, and market access community. We welcome guest bloggers.

Check your inbox or spam folder to confirm your subscription.

Recent Posts

  • The Emerging Outcomes Demonstration / Cost Management Challenge
  • Hard to Define, Harder to Find Patients: Using AI & Real-World Data to Understand Treatment Resistant Depression
  • Get to Know R-S-S (Regulatory Scientific and Health Solutions)
  • Will 2023 Be the Year AI Disrupts Healthcare?

HealthEconomics.Com Twitter Feed

HealthEconomics.Com | A Scientist.com Company Follow

www_healthecon
www_healthecon HealthEconomics.Com | A Scientist.com Company @www_healthecon ·
28 Mar

Improving Image Guided Therapy with Real-World Data

http://ow.ly/VSm450Nu759

#HEOR #RWE #RWD #Healthcare

Reply on Twitter 1640821436343304195 Retweet on Twitter 1640821436343304195 Like on Twitter 1640821436343304195 Twitter 1640821436343304195
www_healthecon HealthEconomics.Com | A Scientist.com Company @www_healthecon ·
28 Mar

Amgen Facing Stiff Resistance in US Supreme Court Patent Case

http://ow.ly/IlFx50Nu6iH

#HEOR #Therapeutics #Pharma #Patents

Reply on Twitter 1640806353303109633 Retweet on Twitter 1640806353303109633 Like on Twitter 1640806353303109633 Twitter 1640806353303109633
www_healthecon HealthEconomics.Com | A Scientist.com Company @www_healthecon ·
28 Mar

The Growing Impact of Health Economics

http://ow.ly/ezF950Nu3Nc

#HEOR #Healthcare #RWE #RWD

Reply on Twitter 1640791377800773632 Retweet on Twitter 1640791377800773632 Like on Twitter 1640791377800773632 Twitter 1640791377800773632
Load More...

Archives

Visit our website, HealthEconomics.Com, top ranked by Google for news, jobs and resources in healthcare value, market access and more. Read our privacy policy here.
© 2023 tHEORetically Speaking. All rights reserved.
Hiero by aThemes